Searched over 200M research papers
10 papers analyzed
These studies suggest that treatment for polycystic ovary syndrome (PCOS) should focus on lifestyle modification, medications, and alternative therapies to improve metabolic and hormonal balance, while also considering specific protocols to prevent and manage ovarian hyperstimulation syndrome (OHSS) in assisted reproductive technologies.
19 papers analyzed
Polycystic Ovarian Syndrome (PCOS) is a prevalent endocrine disorder affecting 5% to 15% of women of reproductive age. It is characterized by a combination of metabolic and reproductive abnormalities, including irregular menstrual cycles, hirsutism, and infertility . The optimal therapeutic approach for PCOS remains a subject of ongoing research and debate.
Lifestyle modification, particularly weight loss, is considered the first-line treatment for PCOS. Even a modest weight loss of 5% can significantly improve the endocrine profile, enhance ovulation, and increase the likelihood of pregnancy . Lifestyle changes typically include dietary adjustments and increased physical activity.
Clomiphene citrate (CC) is often the first-line pharmacologic therapy for inducing ovulation in women with PCOS. For those who are resistant to CC, alternative treatments include the addition of metformin, laparoscopic ovarian drilling, or gonadotropins . Letrozole, an aromatase inhibitor, is also considered an effective alternative for CC-resistant patients.
Metformin, an insulin sensitizer, is frequently used to manage insulin resistance associated with PCOS. It can be combined with other ovulation induction agents to improve outcomes .
Laparoscopic ovarian drilling (LOD) is a surgical option for women who do not respond to pharmacological treatments. This procedure can help restore ovulation by reducing androgen levels in the ovaries .
In cases where other treatments fail, In Vitro Fertilization (IVF) is considered a viable option. The 'short' antagonist-based protocol is preferred for PCOS patients due to its lower risk of ovarian hyperstimulation syndrome (OHSS).
Chinese herbal medicine (CHM) has been explored as an alternative treatment for subfertile women with PCOS. Some studies suggest that CHM, when combined with clomiphene, may improve pregnancy rates. However, the overall quality of evidence is very low, and there is insufficient data on live birth rates and adverse events .
OHSS is a serious complication associated with assisted reproductive technology (ART). Identifying high-risk individuals, such as those with high serum estradiol levels or multiple follicular responses, is crucial for prevention. Effective strategies include using GnRH antagonist protocols and GnRH agonists to trigger final oocyte maturation .
Treatment of OHSS involves meticulous fluid and electrolyte management, paracentesis for ascites, and the use of dopamine receptor agonists like Cabergoline. Severe cases may require intensive care and, in extreme situations, therapeutic interruption of early gestation .
The management of PCOS involves a multifaceted approach, including lifestyle modifications, pharmacological treatments, surgical interventions, and assisted reproductive technologies. While Chinese herbal medicine shows some promise, more high-quality research is needed to confirm its efficacy and safety. Preventing and managing OHSS remains a critical aspect of treatment for women undergoing ART. Further research is essential to refine these treatment strategies and improve outcomes for women with PCOS.
Most relevant research papers on this topic